Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > we stay
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(636)
•••
Comment by okgonowon May 17, 2024 11:11am
90 Views
Post# 36045495

RE:RE:we stay

RE:RE:we stay
QContinuum1 wrote:
okgonow wrote: this low for much longer i think we will see MPL getting gobbled up by another player at a discount...

probably $.15 a share 

that would suck!!


Nobody is gobbling anyone.  There is no way the board or retail shareholders will vote for that.  If someone is interested enough in LABS to take it out, then they know the value and the board will know they know. 



nothing would surprise me just look at the Alamod Gold Argonaught take over offer lots of shareholders are pizzed they sold Argonaught for pennies on the dollar with POG exploding and with the takeover with shares of Alamos at their high and Argonaughts at their all time low.

the CEO said fair value wiuld be at .14 or .15 in the Q1 CC .....that made me say >whhhhhhat<????????

so i think it sure looks like the board would support an offer at .16 and the company takeing over MPL could tout a 100% + premium to SP over the past 3 months.


Seriously nothing would surprise me at this point 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities